安徽医药
安徽醫藥
안휘의약
ANHUI MEDICAL AND PHARMACEUTICAL JOURNAL
2015年
6期
1103-1106
,共4页
肖春花%张春兰%陈伟烈%魏绍静
肖春花%張春蘭%陳偉烈%魏紹靜
초춘화%장춘란%진위렬%위소정
荧光定量PCR%HBVcccDNA水平%检测差异%对比
熒光定量PCR%HBVcccDNA水平%檢測差異%對比
형광정량PCR%HBVcccDNA수평%검측차이%대비
fluorescence quantitative PCR%HBVcccDNA level%detective differences%contrast
目的:研究对比不同荧光定量聚合酶链反应PCR对于乙型肝炎病毒HBVcccDNA水平的检测差异。方法选择20例从2007—2008年在广州市第八人民医院接受住院治疗的乙肝患者作为研究对象。提取其血清及肝组织进行实验分析,另取2份不含HBV感染的患者血清和肝组织作阴性对照组。将其中经或未经脱氧核糖核酸酶DNase处理的样本分别使用HBVc-ccDNA跨单缺口PCR和跨双缺口PCR检测。分析TaqMan探针跨单缺口PCR测定HBVcccDNA的结果,对比跨单、双缺口PCR测定结果以及不同荧光定量PCR的测定结果。分析血清和肝组织中HBVDNA与HBVcccDNA病毒载量的关系。结果血清及肝组织经过DNase消化后的有关拷贝数显著低于未消化者。血清和肝组织跨双缺口PCR测定结果较跨单缺口PCR测定结果均显著降低。血清中的HBVDNA及cccDNA实验结果均显著低于在肝组织中的测定结果,差异均有统计学意义(均P<0.05)。阴性对照组经四种荧光定量PCR检测后均呈阴性。20例E抗原呈阳性的乙肝病人,其机体病毒载量总体趋势为血清HBVDNA的载量较肝组织更低,差异显著。结论 DNase 可有效减少 HBVcccDNA 在检测过程中的假阳性情况,经DNase处理后的跨双缺口PCR检测特异性最高。同时,血清中基本不含cccDNA。
目的:研究對比不同熒光定量聚閤酶鏈反應PCR對于乙型肝炎病毒HBVcccDNA水平的檢測差異。方法選擇20例從2007—2008年在廣州市第八人民醫院接受住院治療的乙肝患者作為研究對象。提取其血清及肝組織進行實驗分析,另取2份不含HBV感染的患者血清和肝組織作陰性對照組。將其中經或未經脫氧覈糖覈痠酶DNase處理的樣本分彆使用HBVc-ccDNA跨單缺口PCR和跨雙缺口PCR檢測。分析TaqMan探針跨單缺口PCR測定HBVcccDNA的結果,對比跨單、雙缺口PCR測定結果以及不同熒光定量PCR的測定結果。分析血清和肝組織中HBVDNA與HBVcccDNA病毒載量的關繫。結果血清及肝組織經過DNase消化後的有關拷貝數顯著低于未消化者。血清和肝組織跨雙缺口PCR測定結果較跨單缺口PCR測定結果均顯著降低。血清中的HBVDNA及cccDNA實驗結果均顯著低于在肝組織中的測定結果,差異均有統計學意義(均P<0.05)。陰性對照組經四種熒光定量PCR檢測後均呈陰性。20例E抗原呈暘性的乙肝病人,其機體病毒載量總體趨勢為血清HBVDNA的載量較肝組織更低,差異顯著。結論 DNase 可有效減少 HBVcccDNA 在檢測過程中的假暘性情況,經DNase處理後的跨雙缺口PCR檢測特異性最高。同時,血清中基本不含cccDNA。
목적:연구대비불동형광정량취합매련반응PCR대우을형간염병독HBVcccDNA수평적검측차이。방법선택20례종2007—2008년재엄주시제팔인민의원접수주원치료적을간환자작위연구대상。제취기혈청급간조직진행실험분석,령취2빈불함HBV감염적환자혈청화간조직작음성대조조。장기중경혹미경탈양핵당핵산매DNase처리적양본분별사용HBVc-ccDNA과단결구PCR화과쌍결구PCR검측。분석TaqMan탐침과단결구PCR측정HBVcccDNA적결과,대비과단、쌍결구PCR측정결과이급불동형광정량PCR적측정결과。분석혈청화간조직중HBVDNA여HBVcccDNA병독재량적관계。결과혈청급간조직경과DNase소화후적유관고패수현저저우미소화자。혈청화간조직과쌍결구PCR측정결과교과단결구PCR측정결과균현저강저。혈청중적HBVDNA급cccDNA실험결과균현저저우재간조직중적측정결과,차이균유통계학의의(균P<0.05)。음성대조조경사충형광정량PCR검측후균정음성。20례E항원정양성적을간병인,기궤체병독재량총체추세위혈청HBVDNA적재량교간조직경저,차이현저。결론 DNase 가유효감소 HBVcccDNA 재검측과정중적가양성정황,경DNase처리후적과쌍결구PCR검측특이성최고。동시,혈청중기본불함cccDNA。
Objective To study detective differences of different fluorescence quantitative PCR for HBVcccDNA levels.Methods 20 cases of hepatitis b were selected from 2007 to 2008 in the Eighth People's Hospital.We analyzed the extracted serum and liver tissues from these patients,and used the other 2 samples of serum and liver tissues from patients without HBV infection as the negative control group.Samples with or without DNase treatment were tested with HBVcccDNA across double gap or single gap PCR detection.We ana-lyzed the testing results of HBVcccDNA by across single gap PCR TaqMan probe measurement,and compared the results between across the single and double gap PCR and different fluorescent quantitative PCR.We also investigated the relationship between HBVDNA and HBVcccDNA viral load in serum and liver tissues.Results The copy number of the serum and liver tissues after DNase digestion was significantly lower than the undigested ones.Results obtained using across double gap PCR were significantly reduced than that using single gap PCR The serum HBVDNA and cccDNA were significantly lower than liver tissues,which were statistically significantly differ-ent (all P <0.05).Testing results were all negative in negative control group using four kinds of fluorescent quantitative’s PCRs.In the 20 cases with hepatitis b positive E antigen,the overall trend of serum HBVDNA viral load capacity was relatively lower than liver tissues,which showed significant difference.Conclusions DNase can effectively reduce HBVcccDNA false positives in the testing process,and cross double gap PCR shows highest detection specificity after DNase treatment.In addition,no cccDNA was observed in serum.